Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCL2 | P10415 | 4/20 | 0.67 |
| ▸ | MCL1 | Q07820 | 4/20 | 0.67 |
| ▸ | MEN1 | O00255 | 4/20 | 0.54 |
| ▸ | MAOA | P21397 | 4/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.54 |
| ▸ | MAPT | P10636 | 3/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.54 |
| ▸ | HPGD | P15428 | 2/20 | 0.54 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.54 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.54 |
| ▸ | RECQL | P46063 | 2/20 | 0.54 |
| ▸ | DAPK1 | P53355 | 2/20 | 0.54 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.54 |
| ▸ | APEX1 | P27695 | 1/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.54 |
| ▸ | PTPN1 | P18031 | 4/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29632886 | 1.00 | BCL2 (0.67) | BCL2MCL1MEN1MAOAKMT2A | |
| SCHEMBL30614616 | 0.86 | TTR (0.62) | BCL2MCL1MEN1MAOAKMT2A | |
| SCHEMBL30040402 | 0.85 | BCL2 (0.56) | BCL2MCL1MEN1MAOAKMT2A | |
| SCHEMBL23199018 | 0.83 | BCL2 (0.61) | BCL2MCL1MEN1MAOAKMT2A | |
| SCHEMBL29883912 | 0.82 | MEN1 (0.55) | BCL2MCL1MEN1MAOAKMT2A | |
| SCHEMBL31139082 | 0.81 | BCL2 (0.59) | BCL2MCL1MEN1MAOAKMT2A | |
| SCHEMBL30038906 | 0.81 | BCL2 (0.59) | BCL2MCL1MEN1MAOAKMT2A | |
| SCHEMBL16227056 | 0.81 | BCL2 (0.59) | BCL2MCL1MEN1MAOAKMT2A | |
| SCHEMBL17867273 | 0.81 | BCL2 (0.64) | BCL2MCL1MEN1MAOAKMT2A | |
| SCHEMBL555230 | 0.80 | BCL2 (1.00) | BCL2MCL1MEN1MAOAKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 307 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3888670-B1 | DRUG FOR TREATING LEUKOPENIA, PREPARATION METHOD THEREFOR AND USE THEREOF | MONYAN PHARMACEUTICAL CO LTD (CN) | 2025-12-24 | — | — | EP | claimed |
| EP-4438281-A1 | DIP-TINTING OPHTHALMIC LENSES WITH NATURAL DYES | Essilor International (FR) | 2024-10-02 | — | — | EP | claimed |
| US-11801280-B2 | Drug for treating leukopenia, preparation method thereof and use thereof | HUBEI MONYAN PHARMACEUTICAL CO., LTD. (CN) | 2023-10-31 | — | — | US | claimed |
| CN-115245533-B | Application of Nanshan flower root extract in treating pulmonary fibrosis | 中国医学科学院药物研究所 | 2023-07-28 | — | — | CN | claimed |
| WO-2022228095-A1 | APPLICATION OF PRISMATOMERIS CONNATA Y. Z. RUAN ROOT EXTRACT IN PREPARATION OF MEDICINE FOR TREATING PULMONARY FIBROSIS | 中国医学科学院药物研究所 | 2022-11-03 | — | — | WO | claimed |
| CN-115245533-A | Application of south mountain flower root extract in pulmonary fibrosis treatment | 中国医学科学院药物研究所 | 2022-10-28 | — | — | CN | claimed |
| CN-112014481-B | Detection method of raw white oral liquid fingerprint spectrum | 湖北梦阳药业股份有限公司 | 2022-10-25 | — | — | CN | claimed |
| CN-112007114-B | Medicine for treating leucopenia and preparation method and application thereof | 湖北梦阳药业股份有限公司 | 2022-05-13 | — | — | CN | claimed |
| EP-3943085-A2 | TOMM6-INTERACTING EXTRACTS AND COMPOUNDS FOR USE IN THE TREATMENT AND PROPHYLAXIS OF NERVOUS SYSTEM DISEASES, ATHEROSCLEROSIS, HEPATITIS B INFECTION AND HUMAN PAPILLOMA VIRUS (HPV) INFECTION | ETH Zurich (CH) | 2022-01-26 | — | — | EP | claimed |
| CN-108318311-B | Hard bone specific calcium fluorescent staining method and application thereof | 复旦大学 | 2022-01-18 | — | — | CN | claimed |
| CN-112007114-A | Medicine for treating leucopenia and preparation method and application thereof | 湖北梦阳药业股份有限公司 | 2020-12-01 | — | — | CN | claimed |
| CN-111840189-A | Production process of black garlic moisturizing cream | 山东钰财农业发展有限公司 | 2020-10-30 | — | — | CN | claimed |
| WO-2015144617-A1 | METHOD FOR PREPARING A PURIFIED MADDER ROOT EXTRACT | RUBIA EXPLOITATIE B.V. (NL) | 2015-10-01 | — | — | WO | claimed |
| EP-2924076-A1 | Method for preparing a purified madder root extract | Rubia Exploitatie B.V. (NL) | 2015-09-30 | — | — | EP | claimed |
| US-20110033525-A1 | Diterpene Glycosides as Natural Solubilizers | BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE | 2011-02-10 | — | — | US | claimed |
| EP-2276463-A2 | DITERPENE GLYCOSIDES AS NATURAL SOLUBILIZERS | Board of Supervisors of Lousiana State University (US) | 2011-01-26 | — | — | EP | claimed |
| WO-2009126950-A2 | DITERPENE GLYCOSIDES AS NATURAL SOLUBILIZERS | BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE (US) | 2009-10-15 | — | — | WO | claimed |
| US-20030082101-A1 | Accelerators for increasing the rate of formation of free radicals and reactive oxygen species | CAVALIER DISCOVERY | 2003-05-01 | — | — | US | claimed |
| WO-2002100478-A9 | ACCELERATORS FOR INCREASING THE RATE OF FORMATION OF FREE RADICALS AND REACTIVE OXYGEN SPECIES | CAVALIER DISCOVERY (US) | 2003-03-27 | — | — | WO | claimed |
| WO-2002100478-A2 | ACCELERATORS FOR INCREASING THE RATE OF FORMATION OF FREE RADICALS AND REACTIVE OXYGEN SPECIES | CAVALIER DISCOVERY (US) | 2002-12-19 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030082101-A1 | Accelerators for increasing the rate of formation of free radicals and reactive oxygen species | SOD1, SOD3, APEX1 | BCL2 410/4885MCL1 347/4885MEN1 3202/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.